🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. Metformin Actavis 500 mg filmdragerad tablett

    The George Institute

    Polycystic ovary syndrome

    approved small molecule active

    1 trial

  2. Methadone

    Pacira Ireland Limited

    Adolescent Idiopathic Scoliosis

    approved small molecule completed

    1 trial

  3. Methimazole

    The First People's Hospital of Lianyungang

    Graves Disease

    approved small molecule active

    1 trial

  4. Methotrexate 2,5 mg film-coated tablets, Simponi 50 mg solution for injection in pre-filled syringe., Hydroxychloroquine sulfate 200mg film-coated Tablets, Cimzia 200 mg solution for injection in pre-filled syringe, Depo-Medrol 80 mg/2 ml Injektionssuspension, Leflunomide Aurobindo 20 mg compresse rivestite con film, Enbrel 50 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Sulfasalazine 500 mg Tablets, Jyseleca 200 mg film-coated tablets, Kenacort

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

  5. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Carboxylesterase 1 (CES1) Genotype

    approved small molecule completed

    2 trials

  6. Methylprednisolone (Injectable Form)

    Universal Integrated

    Unruptured Intracranial Aneurysms

    approved small molecule active

    1 trial

  7. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  8. Metronidazole vaginal suppositories

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  9. Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule

    The George Institute

    lumbosacral radiculalgia

    approved small molecule active

    1 trial

  10. Mifepristone tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uterine Fibroid

    approved small molecule terminated

    1 trial

  11. Minocycline

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    2 trials

  12. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial

  13. Mometasone

    Universal Integrated

    Rhinitis, Allergic, Seasonal

    approved small molecule completed

    1 trial

  14. Mometasone Furoate Nasal Spray (MFNS)

    Universal Integrated

    Seasonal Allergic Rhinitis

    approved small molecule completed

    1 trial

  15. Montelukast

    The First People's Hospital of Lianyungang

    Sinusitis

    approved small molecule completed

    1 trial

  16. Morfina cloridrato S.A.L.F. 10 mg/ml soluzione iniettabile, ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M. 10 mg/ml soluzione iniettabile, CATAPRESAN 150 microgrammi/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    cesarean section

    approved small molecule active

    1 trial

  17. Morphine

    COLLEGIUM PHARMACEUTICAL, INC

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial

  18. Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  19. Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial

  20. Mysimba 8 mg/90 mg prolonged-release tablets

    Disc Medicine

    Obesity, Obesity Surgery

    approved small molecule active

    1 trial

  21. NAABAK eyedrops

    Laboratoire HRA Pharma

    Allergic Conjunctivitis

    approved small molecule completed

    1 trial

  22. Namuscla 167 mg hard capsules, Mexiletine 62 mg hard capsules, Mexiletine 83 mg hard capsules

    Lupin Europe GmbH

    Myotonic disorders: Nondystrophic myotonias (NDM) or myotonic dystrophies (DM, type 1 or type 2)

    approved small molecule active

    1 trial

  23. Neffy

    Ars Pharmaceuticals Irl Limited

    Allergic Reactions

    approved small molecule active

    1 trial

  24. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources